Phiwe Babalo Nota

Dr. Phiwe Babalo Nota

HEARD, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
GGGavin George
Gavin George
Phiwe Babalo NotaPhiwe Babalo Nota
Phiwe Babalo Nota
MSMichael Strauss
Michael Strauss
ELEmma Lansdell
Emma Lansdell
RPRemco Peters
Remco Peters
DWDouglas Wassenaar
Douglas Wassenaar
Healthcare workers (HCWs) were the first population group offered coronavirus disease 2019 (COVID-19) vaccines in South Africa because they were considered to be at higher risk of infection and required protecting as they were a critical resource to the health system. In some contexts, vaccine uptake among HCWs has been slow, with several studies citing persistent concerns about vaccine safety and effectiveness. This study aimed to determine vaccine uptake among HCWs in South Africa whilst identifying what drives vaccine hesitancy among HCWs. We adopted a multimethod approach, utilising both a survey and in-depth interviews amongst a sample of HCWs in South Africa. In a sample of 7763 HCWS, 89% were vaccinated, with hesitancy highest among younger HCWs, males, and those working in the private sector. Among those who were hesitant, consistent with the literature, HCWs raised concerns about the safety and effectiveness of the vaccine. Examining this further, our data revealed that safety and effectiveness concerns were formed due to first-hand witnessing of patients presenting with side-effects, concern over perceived lack of scientific rigor in developing the vaccine, confidence in the body’s immune system to stave off serious illness, and both a general lack of information and distrust in the available sources of information. This study, through discursive narratives, provides evidence elucidating what drives safety and effectiveness concerns raised by HCWs. These concerns will need to be addressed if HCWs are to effectively communicate and influence public behaviour. HCWs are key role players in the national COVID-19 vaccination programme, making it critical for this workforce to be well trained, knowledgeable, and confident if they are going to improve the uptake of vaccines among the general population in South Africa, which currently remains suboptimal.

20 November 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
GGGavin George
Gavin George
Phiwe Babalo NotaPhiwe Babalo Nota
Phiwe Babalo Nota
MSMichael Strauss
Michael Strauss
ELEmma Lansdell
Emma Lansdell
RPRemco Peters
Remco Peters
DWDouglas Wassenaar
Douglas Wassenaar
This study aimed examin the factors associated with the uptake and non-acceptance of COVID-19 vaccine booster doses among healthcare workers (HCWs) in South Africa. We used a mixed-methods design with data from a web-based self-administered survey followed by semi-structured in-depth interviews (IDIs) with selected participants. Of the 6235 HCWs included in our analysis who had fully vaccinated, 3470 (56%) had taken their booster dose with a further 17% intending to get the booster. HCWs aged 35 to 49 years (OR = 1.30 [95% CI: 1.15–1.46]), and those aged 50 years or older (OR = 2.66 [95% CI: 2.32–3.05]) were more likely to get the booster dose. Females were less likely to have received the booster dose (OR = 0.88 [95% CI: 0.79–0.98]) with doctors more likely (OR = 1.58 [95% CI: 1.35–1.84]) than Nurses to have received the booster dose. HCWs in direct contact with patients (OR = 1.17 [95% CI: 1.00–1.38]) and who had previously received a flu vaccine (OR = 1.99 [95% CI: 1.56–2.55]) were more likely to have received the booster dose. Four themes emerged from the qualitative data analysis: (1) Vaccination as routine practice among HCWs; (2) Emergence of new COVID-19 variants necessitating vaccine boosters; (3) Fear of potential side-effects; and (4) Limited value of COVID-19 vaccine boosters. Some HCWs broadly accepted the value of vaccination, and believed that boosters were necessary to effectively combat emergent new virus strains, which contrasted with peers who believed that boosters offered little defence against virus mutations. Fear prohibited some HCWs from getting the booster, with some having experienced adverse side effects from their initial vaccination, whilst others were concerned about future complications. Waning booster uptake rates could be arrested through invigorated communication strategies, while effective evidence-based training can potentially create positive normative vaccination practices amongst HCWs.

6 October 2022 in Communicare: Journal for Communication Studies in Africa
Verified
Journal Article
Open access
EGELIZA MELISSA GOVENDER
ELIZA MELISSA GOVENDER
YVYonela Vukapi
Yonela Vukapi
Phiwe Babalo NotaPhiwe Babalo Nota
Phiwe Babalo Nota
HIV and AIDS remain one of the leading public health challenges in the world, with young women in sub-Saharan Africa bearing the brunt of HIV infection. Female vulnerability to HIV infection is exacerbated by socio-cultural, economic and biological dynamics. Vaginal microbicide, one of the first topical pre-exposure prophylaxis (PrEP) innovations for HIV prevention can offer new hope for women, but an understanding of the local cultural context and its influence on product acceptability is fundamental for effective HIV communication strategies. Critical health communication navigates through the complexities of cultural discourses to create awareness among women in dominant cultural settings. As a means of understanding the key determinants for effective HIV communication, this paper used thematic analysis of data from a study among female students at the University of KwaZulu-Natal regarding their preferences and the acceptability of two microbicide technologies: the tenofovir gel and the dapivirine ring. Keyfindings indicate that microbicides give women more options for self-protection and cater for diverse sexual encounters, and that their covert use empowers women to use the products even if male partners do not support this. However, women felt more empowered with “male-supported, female-initiated” HIV prevention options. The study suggests that in providing HIV preventionoptions to women, culturally appropriate messages must be considered. We suggested that topical PrEP must be communicated as a “male-supported, female-initiated” HIV prevention option in rural KwaZulu-Natal contexts.

10 September 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
TMThokozile J Mbaya
Thokozile J Mbaya
Phiwe Babalo NotaPhiwe Babalo Nota
Phiwe Babalo Nota
NGNonjabulo Purity Gwala
Nonjabulo Purity Gwala
CFChristopher M Ferraris
Christopher M Ferraris
CMChristopher Magana
Christopher Magana
GGGavin George
Gavin George
Background: Despite increasing recognition of adolescents’ and young adults’ mental health needs, many young people continue to experience barriers in accessing timely, acceptable, and responsive mental health and psychosocial support (PSS) services. There is a need for contextually relevant and youth-responsive approaches that meaningfully engage young people, caregivers, and service providers in implementation strategy development. The Asenze Impilo study aims to co-design a mental health and PSS implementation strategy for adolescents and young adults in KwaZulu-Natal (KZN), South Africa, using a human-centered design (HCD) approach. Objective: This protocol paper describes the methods used to co-design an implementation strategy to enhance existing mental health and PSS services for adolescents and young adults, leveraging resources from the Asenze study, a population-based longitudinal cohort study in KZN, South Africa. The study will use an HCD approach to engage adolescents and young adults, caregivers, and various mental health stakeholders from the Departments of Health, Basic Education, and Social Development, and implementing partner organizations in order to inform how to improve mental health for adolescents and young adults by (1) identifying needs and barriers, (2) developing context-relevant solutions, and (3) refining a co-designed implementation strategy. Methods: A 3-phase HCD co-design process will be undertaken, using qualitative multimethods. Participants will include 20 young adults recruited from the Asenze study, 20 caregivers recruited from the Asenze study, and 15 mental health stakeholders from KZN, South Africa. Phase 1, Discover , includes separate HCD workshops with adolescents and young adults, caregivers, and implementation partners to understand existing mental health and PSS services, mental health and PSS needs of adolescents and young adults, and potential evidence-based intervention options and corresponding implementation strategies. Phase 2, Design , includes separate HCD workshops with adolescents and young adults and caregivers to co-design a context-specific mental health and PSS implementation strategy. Phase 3, Build , includes 2 separate HCD workshops with adolescents and young adults and caregivers to refine the co-designed implementation strategy, and a consultation workshop with the mental health stakeholders to review the feasibility and acceptability of the proposed implementation strategy. A qualitative thematic analysis approach will be used, allowing for an inductive and iterative exploration of patterns emerging from the data collected during the HCD workshops. Results: The study was funded in 2024, and ethics approval was received in March 2025. Enrollment will be completed in April 2025, and data collection will be conducted between May 2025 and January 2026. Findings are expected to be submitted for publication later in 2026. Conclusions: The study aims to produce a co-designed implementation strategy to improve delivery of mental health and PSS for adolescents and young adults that is adapted to the local context.